nsaction for $5.50 per share (the "Revised Offer") provided that Cypress commences exclusive negotiations with V&O Acquisition no later than Friday, December 10, 2010 and enters into a definitive merger agreement no later than Sunday, December 12, 2010. V&O Acquisition's current tender offer is scheduled to expire on Friday, December 10, 2010. To facilitate discussions, V&O Acquisition will be extending its existing tender offer for an additional five (5) business days, but reserves the right to terminate the tender offer at any time.
As of the date hereof, affiliates of Royalty Pharma Finance Trust ("Royalty Pharma") have indicated that they are prepared to invest approximately $196 million in cash in the equity of V&O Acquisition to enable V&O Acquisition to pay the amount payable to stockholders of Cypress pursuant to the Revised Offer. Royalty Pharma's financing is not subject to due diligence or any other material condition. However, Royalty Pharma has advised Ramius that it reserves the right to withdraw this financing arrangement if Cypress has not commenced exclusive negotiations with V&O Acquisition by midnight on Friday, December 10, 2010 and has not entered into a definitive merger agreement by midnight on Sunday, December 12, 2010.
V&O Acquisition believes that, as a result of its pending tender offer, it is able to acquire Cypress and pay the stockholders of Cypress the full value of their shares more quickly than any other potential bidder. V&O Acquisition has completed all required due diligence and has sufficient funds to promptly close the tender offer.
V&O Acquisition is willing to enter into a merger agreement giving effect to the Revised Offer, which is of significant value and brings immediate certainty to Cypress and its stockholders. The terms would include the following:
Page: 1 2 3 4 5 6 Related biology technology :1
- All cash offer of $5.50 per share.<
. Cypress Denies Ramius Legal Right to Stockholder List Materials2
. UC San Diego Offers New Certificate for Clinical Trials Administration in Latin America3
. U of C scientist offers better ways to engineer Earths climate to prevent dangerous global warming4
. Emerson Ecologics Exclusively Offers EcoNugenics ProstaCaid5
. New paper offers breakthrough on blinking molecules phenomenon6
. Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome 7
. Research from Rensselaer Polytechnic Institute professor offers clues to Alzheimers disease8
. Carl Zeiss Offers Online Promotions – Discounts on Stereomicroscopy and Converting to 3D Imaging9
. MD Biosciences Offers Occlusion-induced Myocardial Infarct Model for Investigating the Cardio-protection of a Drug Treatment in the Event of Ischemia/reperfusion Injury10
. Summit Dental Institute Offers A Hands-On One-Day Imtec MDI Mini Dental Implant Certification Course For Dentists 11
. Michael Youssef Offers Insight into the Muslim Perspective on Oil and the World Economy